The current analyst and expert consensus on Quest Diagnostics is Hold with 12 hold recommendations. The current projected target price consensus is 90.75 with 12 analysts opinions. One of the most common ways Quest Diagnostics In analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Quest Diagnostics vendors, executives, and/or customers. Quest Diagnostics recommendation module provides expert sentiment on the projected Quest Diagnostics In target price to derive its highest and lowest estimates based on target price standard deviation of 9.352. Additionally see Macroaxis Advice on Quest Diagnostics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.